Expression of cytochrome P 450 3A enzymes in human lung: A combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 2, 1996, Pages 207-212

  Kivistö, Kari T ^a   Griese, Ernst Ulrich ^a   Fritz, Peter ^b   Linder, Albert ^c   Hakkola, Jukka ^d   Raunio, Hannu ^d   Beaune, Philippe ^e   Kroemer, Heyo K ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b Pathologisches Inst am Robert B   (Germany)

^c Klinik Schillerhohe   (Germany)

^d UNIVERSITY OF OULU   (Finland)

^e INSERM   (France)

Author keywords

CYP3A; Cytochrome P 450; Human lung

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOCHROME P450 ISOENZYME; IFOSFAMIDE; MESSENGER RNA; CYTOCHROME P450;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG CARCINOMA; LUNG TUMOR; MALE; METABOLIC ACTIVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

AGED; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0029671226     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 264:10388-10395
2. Beaune P, Kremers P, Letawe-Goujon F, Gielen JE (1985) Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 34:3547-3552
3. Boddy AV, Proctor M, Simmonds D, Lind MJ, Idle JR (1995) Pharmacokinetics, metabolism and clincal effect of ifosfamide in breast cancer patients. Eur J Cancer 31A:69-76
4. Botsch S, Gautier J-C, Beaune P, Eichelbaum M, Kroemer HK (1993) Identification and characterization of the cytochrome P 450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Mol Pharmacol 43:120-126
5. Chang TKH, Weber GF, Crespi CL, Waxman DJ (1993) Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res 53:5629-5637
6. Dechant KL, Brogden RN, Pilkington T, Faulds D (1991) Ifosfamide/ mesna: a review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 42:428-467
7. Fritz P, Mueller J, Wegner G, Braun U, Grau A, Tuczek HV, Moessner E, Schenk R (1985) Immunohistochemie: Theoretische Möglichkeiten, praktische Anwendungen. Zlbl Allg Pathol Anat 130:187-193
8. Fritz P, Behrle E, Beaune P, Eichelbaum M, Kroemer HK (1993) Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P 450 3A and glutathione-S-transferase. Histochemistry 99:443-451
9. Gillam EMJ, Guo Z, Ueng Y-F, Yamazaki H, Cock I, Reilly PEB, Hooper WD, Guengerich FP (1995) Expression of cytochrome P 450 3A5 in Escherichia coli: effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch Biochem Biophys 317:374-384
10. Gonzalez FJ, Idle JR (1994) Pharmacogenetic phenotyping and genotyping: present status and future potential. Clin Pharmacokinet 26:59-70
11. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR (1988) Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P 450PCN1 is nifedipine oxidase. DNA 7:79-86
12. Guengerich FP (1993) Bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metab Dispos 21:1-6
13. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genomic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051-5060
14. Hsu SM, Raine L, Fanger H (1981) The use of anti-avidin antibody and avidin-biotin-complex in immunoperoxidase techniques. Am J Clin Pathol 75:816-821
15. Hultman T, Stahl S, Hornes E, Uhlen M (1989) Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid supports. Nucleic Acids Res 17:4937-4946
16. Kivistö KT, Fritz P, Linder A, Friedel G, Beaune P, Kroemer HK (1995a) Immunohistochemical localization of cytochrome P 4503A in human pulmonary carcinomas and normal bronchial tissue. Histochemistry 103:25-29
17. Kivistö KT, Linder A, Friedel G, Beaune P, Belloc C, Kroemer HK, Fritz P (1995b) Immunohistochemical localization of cytochrome P4502E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch 426:243-247
18. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB (1994) CYP3A gene expression in human gut epithelium. Pharmacogenetics 4:247-259
19. Komori M, Nishio K, Ohi H, Kitada M, Kamataki T (1989) Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem (Tokyo) 105:161-163
20. Krishna DR, Klotz U (1994) Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 26:144-160
21. Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, Gouyette A, Chabot GG (1992) Comparison of mouse and human colon tumours with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res 52:6567-6575
22. McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333-1339
23. Mimura M, Baba T, Yamazaki H, Ohmori S, Inui Y, Gonzalez FJ, Guengerich FP, Shimada T (1993) Characterization of cytochrome P-450 2B6 in human liver microsomes. Drug Metab Dispos 21:1048-1056
24. Moore MJ (1991) Clinical pharmacokinetics of cyclophosphamide. Clin Phamacokinet 20:194-208
25. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT, Burke MD (1988) The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 25:465-475
26. Murray GI, Weaver RJ, Paterson PJ, Ewen SWB, Melvin WT, Burke MD (1993) Expression of xenobiotic metabolizing enzymes in breast cancer. J Pathol 169:347-353
27. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423
28. Walker D, Ranu HK, Pearson ADJ, Idle JR (1995) Cytochrome P 450 3A5 (CYP3A5) makes a significant contribution to the metabolism in vitro of cyclophosphamide and ifosfamide. Proc Am Assoc Cancer Res 36:2224
29. Yule SM, Boddy AV, Cole M, Price L, Wyllie R, Tasso MJ, Pearson ADJ, Idle JR (1995) Cyclophosphamide metabolism in children. Cancer Res 55:803-809